(Q56896907)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668348%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

title

Human hepatocellular carcinoma-infiltrating CD4⁺CD69⁺Foxp3⁻ regulatory T cell suppresses T cell response via membrane-bound TGF-β1 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668348%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668348%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

author name string

Yanmei Han

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668348%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Yuan Yang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668348%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Zhubo Chen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668348%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Zhengping Jiang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668348%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Yan Gu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668348%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Yanfang Liu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668348%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Chuan Lin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668348%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Zeya Pan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668348%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Weiping Zhou

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668348%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Xuetao Cao

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668348%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

language of work or name

English

0 references

publication date

26 March 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668348%20AND%20SRC:MED&resulttype=core&format=json

Journal of Molecular Medicine

12 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668348%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

volume

92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668348%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668348%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

page(s)

539-550

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668348%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00109-014-1143-4

12 March 2020

exact match

0 references

cites work

Regulatory T cells: mechanisms of differentiation and function

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Induced CD4+Foxp3+ regulatory T cells in immune tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Is FOXP3 a bona fide marker for human regulatory T cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Rethinking the molecular definition of regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

How regulatory T cells work

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Mechanisms of suppression by suppressor T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Inhibition of follicular T-helper cells by CD8(+) regulatory T cells is essential for self tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Regulation of self-tolerance by Qa-1-restricted CD8(+) regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

CD11c(high)CD8+ regulatory T cell feedback inhibits CD4 T cell immune response via Fas ligand-Fas pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Tumor-educated CD11bhighIalow regulatory dendritic cells suppress T cell response through arginase I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Fas signal promotes lung cancer growth by recruiting myeloid-derived suppressor cells via cancer cell-derived PGE2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Immunosuppressive strategies that are mediated by tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Regulatory T cells, tumour immunity and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Cancer immunotherapy comes of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

The blockade of immune checkpoints in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Regulatory T cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Recognition of a new ARTC1 peptide ligand uniquely expressed in tumor cells by antigen-specific CD4+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

CD69+ CD4+ CD25- T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Human CD14+ CTLA-4+ regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Human T regulatory cells can use the perforin pathway to cause autologous target cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

High frequency of CD4+ CD25- CD69+ T cells is correlated with a low risk of acute graft-versus-host disease in allotransplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Regulation of immune responses by TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Tumor apoptotic bodies inhibit CTL responses and antitumor immunity via membrane-bound transforming growth factor-beta1 inducing CD8+ T-cell anergy and CD4+ Tr1 cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Phenotypic and functional characteristics of CD4+ CD39+ FOXP3+ and CD4+ CD39+ FOXP3neg T-cell subsets in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

CTLA-4 control over Foxp3+ regulatory T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Modulation of tryptophan catabolism by regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1143-4

Human Tumor-Derived Exosomes Selectively Impair Lymphocyte Responses to Interleukin-2

21 January 2018

1 reference

12 December 2020

Apoptotic cells attenuate fulminant hepatitis by priming Kupffer cells to produce interleukin-10 through membrane-bound TGF-β

1 reference

12 December 2020

Activated tumor-infiltrating CD4+ regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer

1 reference

12 December 2020

Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression

1 reference

12 December 2020

10.1007/S00109-014-1143-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668348%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference